Mutations in LAMB2 Are Associated With Albuminuria and Optic Nerve Hypoplasia With Hypopituitarism.
LAMB2
Pierson syndrome
optic nerve hypoplasia syndrome
Journal
The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362
Informations de publication
Date de publication:
01 03 2020
01 03 2020
Historique:
received:
28
05
2019
accepted:
25
11
2019
pubmed:
27
11
2019
medline:
6
11
2020
entrez:
27
11
2019
Statut:
ppublish
Résumé
Mutations in LAMB2, encoding the basement membrane protein, laminin β2, are associated with an autosomal recessive disorder characterized by congenital nephrotic syndrome, ocular abnormalities, and neurodevelopmental delay (Pierson syndrome). This report describes a 12-year-old boy with short stature, visual impairment, and developmental delay who presented with macroscopic hematuria and albuminuria. He had isolated growth hormone deficiency, optic nerve hypoplasia, and a small anterior pituitary with corpus callosum dysgenesis on his cranial magnetic resonance imaging, thereby supporting a diagnosis of optic nerve hypoplasia syndrome. Renal histopathology revealed focal segmental glomerulosclerosis. Using next-generation sequencing on a targeted gene panel for steroid-resistant nephrotic syndrome, compound heterozygous missense mutations were identified in LAMB2 (c.737G>A p.Arg246Gln, c.3982G>C p.Gly1328Arg). Immunohistochemical analysis revealed reduced glomerular laminin β2 expression compared to control kidney and a thin basement membrane on electron microscopy. Laminin β2 is expressed during pituitary development and Lamb2-/- mice exhibit stunted growth, abnormal neural retinae, and here we show, abnormal parenchyma of the anterior pituitary gland. We propose that patients with genetically undefined optic nerve hypoplasia syndrome should be screened for albuminuria and, if present, screened for mutations in LAMB2.
Identifiants
pubmed: 31769495
pii: 5643661
doi: 10.1210/clinem/dgz216
pmc: PMC7048679
pii:
doi:
Substances chimiques
Laminin
0
laminin beta2
124148-86-3
Types de publication
Case Reports
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : NIDDK NIH HHS
ID : R01 DK078314
Pays : United States
Organisme : Medical Research Council
ID : MR/K010654/1
Pays : United Kingdom
Organisme : Department of Health
Pays : United Kingdom
Informations de copyright
© Endocrine Society 2019.
Références
Curr Treat Options Neurol. 2013 Feb;15(1):78-89
pubmed: 23233151
Kidney Int. 2006 Sep;70(6):1008-12
pubmed: 16912710
J Neurosci. 1999 Nov 1;19(21):9399-411
pubmed: 10531444
J Med Genet. 2017 Jul;54(7):441-449
pubmed: 28501829
Development. 2006 Mar;133(5):967-75
pubmed: 16452099
J Am Soc Nephrol. 2008 Jun;19(6):1139-57
pubmed: 18337488
Acta Histochem Cytochem. 2014;47(5):231-7
pubmed: 25861129
Acta Histochem Cytochem. 2015 Dec 25;48(6):185-92
pubmed: 26855451
Hum Mol Genet. 2004 Nov 1;13(21):2625-32
pubmed: 15367484
Hum Mutat. 2010 Sep;31(9):992-1002
pubmed: 20556798